DRKS00033219
Completed
Not Applicable
Prognostic value of cardiopulmonary biomarkers in relation to the development of bronchopulmonary dysplasia and pulmonary hypertension in premature infants
niversitätsklinikum Bonn0 sites90 target enrollmentDecember 13, 2023
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- P27.1
- Sponsor
- niversitätsklinikum Bonn
- Enrollment
- 90
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Birth weight \<1500g
Exclusion Criteria
- •\=30/1 weeks of GA, early death (\<7 days of life), primary palliative care, congenital heart defects (CHD) requiring surgical repair. A patent ductus arteriosus (PDA), an atrial septal defect (ASD, \<5mm) and a muscular ventricular septal defect (VSD, \<2mm) were not classified as relevant CHD.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Identifying and validating predictive and prognostic biomarkers in male Germ Cell Tumours to improve the management and outcomes in both stage 1 and disseminated disease.Germ Cell Tumour (GCT)SeminomaTesticular cancerCancer - TesticularACTRN12618000931279Walter and Eliza Hall Institute for Medical Research800
Not yet recruiting
Not Applicable
Biomarkers in Pancreatic CancerHistologically or cytologically confirmed pancreatic cancerCancer - PancreaticACTRN12616000519459The Walter and Eliza Hall Institute of Medical Research500
Active, not recruiting
Phase 1
The value of blood measurements, ultrasound an muscle electric studies to fortell the outcome of low back pain and sciatic pain and to evaluate the effect of the muscle relaxant tolperisoEUCTR2019-001885-14-HUational Research, Development and Innovation Office150
Not yet recruiting
Not Applicable
study of lab investigations among hospitalized COVID-19 patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/08/027079Dr Swathy Moorthy
Completed
Phase 4
Relevance of Biomarkers and Clinical Predictors of Outcome in Unselected Population with Febrile Urinary Tract Infection at Primary Care and Emergency Department in a Prospective, Randomized Cohort Trial Comparing Short (7 days) Antibiotic Treatment with Conventional Treatment (14 days)febrile urinary tract infection or pyelonephritis1000401810046590NL-OMON39150eids Universitair Medisch Centrum500